Half of the patients were randomly assigned to once-daily dapagliflozin 10 mg (Farxiga, AstraZeneca), started within 2 weeks following TAVR, and the other half received standard care only.

In a reversal of fortune, yesterday (9 April) the UK Court of Appeal awarded AstraZeneca (AZ) an interim injunction keeping Glenmark’s dapagliflozin ... patent on 10-20 March).

"Dapagliflozin reduced UACR compared with ... The study was funded by University Medical Center Groningen and supported by AstraZeneca, which provided the medication. Some authors reported ...